IE38655B1 - Pharmaceutical compositions for treating spasticity - Google Patents

Pharmaceutical compositions for treating spasticity

Info

Publication number
IE38655B1
IE38655B1 IE2267/73A IE226773A IE38655B1 IE 38655 B1 IE38655 B1 IE 38655B1 IE 2267/73 A IE2267/73 A IE 2267/73A IE 226773 A IE226773 A IE 226773A IE 38655 B1 IE38655 B1 IE 38655B1
Authority
IE
Ireland
Prior art keywords
hydroxy
dihydroxyphenyl
butylaminoethane
tert
isopropylaminoethane
Prior art date
Application number
IE2267/73A
Other versions
IE38655L (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IE38655L publication Critical patent/IE38655L/en
Publication of IE38655B1 publication Critical patent/IE38655B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

1453034 Skeletal muscle relaxing preparations BOEHRINGER INGELHEIM GmbH 14 Dec 1973 [15 Dec 1972] 58088/72 Heading A5B . A pharmaceutical composition for use in the treatment of spastically disabled human being comprises a sympathomimetic amine or a physiologically acceptable salt thereof together with an effective amount of sustained or delayed release agent, said amine being: 1-(3, 5-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 1-(4-amino-3, 5-dichlorophenyl) - 1 -hydroxy-2-tert-butylaminoethane; 1-(3-hydroxymethyl -4- hydroxyphenyl) -1- hydroxy -2- tert butylaminoethane; 1-(3, 5 - dihydroxyphenyl) -1- hydroxy -2- (1-(4-hydroxybenzyl) ethyl)-aminoethane; 1-(3, 5-dihydroxyphenyl)- 1 -hydroxy-2-tert butylaminoethane; N, N'-bis- [1-(3, 4-dihydroxyphenyl)-1-hydroxyethyl (2)]- hexamethylenediamine; 1-(3, 4-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 2-[(3, 4-dihydroxyphenyl) hydroxymethyl] piperidinium hydrobromide; 8-hydroxy-5-( 1 -hydroxy-2- isopropylaminoethyl) quinoline; 1-diphenylmethyl-4-hydroxyethoxyethyl-piperazine; 1 -phenethylpiperidine-4-spiro-5'-[1', 3']-oxazolidin-2'- one; and 1-(2-phenyl-2-methoxyethyl)-4-(3-hydroxy-3-phenylpropyl) piperazine. The composition may be in a form suitable for oral or parenteral administration. [GB1453034A]
IE2267/73A 1972-12-15 1973-12-14 Pharmaceutical compositions for treating spasticity IE38655B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5808872A GB1453034A (en) 1972-12-15 1972-12-15 Pharmaceutical composition for treating spasticity

Publications (2)

Publication Number Publication Date
IE38655L IE38655L (en) 1974-06-15
IE38655B1 true IE38655B1 (en) 1978-05-10

Family

ID=10480743

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2267/73A IE38655B1 (en) 1972-12-15 1973-12-14 Pharmaceutical compositions for treating spasticity

Country Status (6)

Country Link
BE (1) BE808662A (en)
DE (1) DE2362123A1 (en)
GB (1) GB1453034A (en)
IE (1) IE38655B1 (en)
IL (1) IL43820A (en)
ZA (1) ZA739480B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574894A (en) * 1977-06-02 1980-09-10 Nippon Kayaku Kk Derivative of a-methyl-aminopropiophenone and use thereof
DE2929456A1 (en) * 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CH656308A5 (en) * 1982-05-27 1986-06-30 Glaxo Group Ltd PHARMACEUTICAL COMPOSITIONS CONTAINING SALBUTAMOL.
US5468501A (en) * 1982-09-01 1995-11-21 Hercon Laboratories Corporation Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
EP0251425B1 (en) * 1986-04-03 1993-06-16 Hercon Laboratories Corporation Article for administration of pharmacologically-active substances

Also Published As

Publication number Publication date
GB1453034A (en) 1976-10-20
IL43820A0 (en) 1974-03-14
IL43820A (en) 1977-08-31
BE808662A (en) 1974-06-14
ZA739480B (en) 1975-08-27
DE2362123A1 (en) 1974-06-20
IE38655L (en) 1974-06-15
AU6364773A (en) 1975-06-19

Similar Documents

Publication Publication Date Title
FI945621A0 (en) Regulated release formulation
GB2254784B (en) Film-coated solid dosage form of anti-migraine drug
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
CZ176495A3 (en) The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes
GEP20043324B (en) Purine Derivatives
IE38655B1 (en) Pharmaceutical compositions for treating spasticity
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
MY124465A (en) Reduction of infarct volume using citicoline
KR900014406A (en) Cefem compound and preparation method thereof
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
TR200103144T2 (en) New compounds
GB2209281B (en) Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist
BR0011880A (en) Method for the treatment of co-morbid conditions associated with obesity, compound, product, use of a compound, and pharmaceutical composition
DE59205998D1 (en) Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation
KR930702985A (en) Treatment of Esophageal Cancer
EP0613375A4 (en) Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof.
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GEP20033054B (en) 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals
KR890701111A (en) Treatment of dyslipidemia in humans
GB1375806A (en)
Muntaner et al. Effects of Nifedipine (A Ca++ Modulator) Pre-treatment on Cardio-vascular and Subjective Responses to Intravenous Cocaine Administration in Humans
CZ176395A3 (en) The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation
JO1664B1 (en) Compomnd with gastric acid inhibitory effect and process for its preparation
IT1271354B (en) Preparation of a pharmaceutical form capable of combating hyperinsulinism